New Weight loss medication alert: RETATRUTIDE. Comparing it to Semaglutide, Retatrutide adds a 3rd receptor that it targets in your endocrine system







RETATRUTIDE: WEIGHT LOSS MEDICATION [S8MwRw3DDE-]

RETATRUTIDE: WEIGHT LOSS MEDICATION [S8MwRw3DDE-]

| 1h 28m 28s | Video has closed captioning.

New Weight loss medication alert: RETATRUTIDE. Comparing it to Semaglutide, Retatrutide adds a 3rd receptor that it targets in your endocrine system to result in even more weight loss. It has approximately 25% reduction in body weight in 48 weeks, and there does not seem to be a plateau after that. This turns around a lot of the signs & symptoms of metabolic syndrome, which can lead to diabetes, fatty liver, etc. In additon it can be helpful for those that have metabolic syndrome, fatty liver disease, and even Type 2 Diabetes. More updates coming soon as we learn more about this new weapon in our fight against metabolic disease. . . . #retatrutide #weightloss #weightlossmedicaiton #weighlossjourney #metabolicsyndrome #diabetes #healthandwellness #nexthealth #drshah #theshahprotocol #shorts #brazil diet pills #genius diet pills

Aired: December 22, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now